| Active surveillance for low-risk prostate cancer worldwide: the PRIAS study M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ... European urology 63 (4), 597-603, 2013 | 615 | 2013 |
| Sequence variant on 8q24 confers susceptibility to urinary bladder cancer LA Kiemeney, S Thorlacius, P Sulem, F Geller, KKH Aben, SN Stacey, ... Nature genetics 40 (11), 1307-1312, 2008 | 496 | 2008 |
| Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer GHJM Leyten, D Hessels, SA Jannink, FP Smit, H de Jong, EB Cornel, ... European urology 65 (3), 534-542, 2014 | 457 | 2014 |
| Detection of high-grade prostate cancer using a urinary molecular biomarker–based risk score L Van Neste, RJ Hendriks, S Dijkstra, G Trooskens, EB Cornel, ... European urology 70 (5), 740-748, 2016 | 414 | 2016 |
| Three-Tesla magnetic resonance–guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound … CMA Hoeks, MG Schouten, JGR Bomers, SP Hoogendoorn, ... European urology 62 (5), 902-909, 2012 | 326 | 2012 |
| Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction MR van BALKEN, V VANDONINCK, KWH GISOLF, H VERGUNST, ... The Journal of urology 166 (3), 914-918, 2001 | 288 | 2001 |
| Identification of a candidate gene panel for the early diagnosis of prostate cancer GHJM Leyten, D Hessels, FP Smit, SA Jannink, H de Jong, WJG Melchers, ... Clinical cancer research 21 (13), 3061-3070, 2015 | 254 | 2015 |
| The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer DM Somford, EH Hamoen, JJ Fütterer, JP Van Basten, ... The Journal of urology 190 (5), 1728-1734, 2013 | 216 | 2013 |
| The use of electrical devices for the treatment of bladder dysfunction: a review of methods MR van BALKEN, H Vergunst, BLH Bemelmans The Journal of urology 172 (3), 846-851, 2004 | 166 | 2004 |
| Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain MR Van Balken, V Vandoninck, BJ Messelink, H Vergunst, ... European urology 43 (2), 158-163, 2003 | 137 | 2003 |
| Prognostic factors for successful percutaneous tibial nerve stimulation MR Van Balken, H Vergunst, BLH Bemelmans European urology 49 (2), 360-365, 2006 | 126 | 2006 |
| Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance–guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer … CMA Hoeks, DM Somford, IM Van Oort, H Vergunst, JR Oddens, GA Smits, ... Investigative radiology 49 (3), 165-172, 2014 | 105 | 2014 |
| Comparison of three schedules of intravesical epirubicin in patients with non–muscle-invasive bladder cancer K Hendricksen, WPJ Witjes, JG Idema, JJM Kums, OB van Vierssen Trip, ... European urology 53 (5), 984-991, 2008 | 105 | 2008 |
| Treatment of high-grade non–muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations … MO Grimm, AG van der Heijden, M Colombel, T Muilwijk, ... European urology 78 (5), 690-698, 2020 | 97 | 2020 |
| Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response AG van der Heijden, PMJ Moonen, EB Cornel, H Vergunst, TM de Reijke, ... The Journal of urology 176 (4), 1349-1353, 2006 | 96 | 2006 |
| MR imaging–guided focal cryoablation in patients with recurrent prostate cancer JGR Bomers, D Yakar, CG Overduin, JPM Sedelaar, H Vergunst, ... Radiology 268 (2), 451-460, 2013 | 76 | 2013 |
| Quality of life after prostate cancer treatments in patients comparable at baseline JJ van Tol-Geerdink, JWH Leer, IM Van Oort, E Van Lin, PC Weijerman, ... British Journal of cancer 108 (9), 1784-1789, 2013 | 76 | 2013 |
| Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid JJ van Tol‐Geerdink, J Willem Leer, PC Weijerman, IM van Oort, ... BJU international 111 (4), 564-573, 2013 | 74 | 2013 |
| Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer DM Somford, CM Hoeks, CA Hulsbergen-Van De Kaa, T Hambrock, ... Investigative radiology 48 (3), 152-157, 2013 | 73 | 2013 |
| Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy D Yakar, T Hambrock, H Huisman, CA Hulsbergen-van de Kaa, E van Lin, ... Investigative radiology 45 (3), 121-125, 2010 | 69 | 2010 |
